Call for Papers  

Article Details

General Review Article

Can Wogonin be Used in Controlling Diabetic Cardiomyopathy?

[ Vol. 25 , Issue. 19 ]


Shahzad Khan* and Mohammad A. Kamal   Pages 2171 - 2177 ( 7 )


Diabetes Mellitus (DM) is now a well-known factor which initiates many metabolic derangements in various tissues and organs including liver, muscle, pancreas, adipose tissue, cardiovascular and nervous system. Cardiovascular complications are the most crucial , and their effects are so intensive that their derangement leads to cardiac failure even in the absence of ischemic heart diseases. This entity of cardiac pathology in DM is often regarded as diabetic cardiomyopathy (DCM). Recently, many plant-derived drugs have been tested to control and alleviate DCM. Wogonin is one of the drugs the characteristics of which have been deeply studied. Wogonin is a flavonoid having yellow color pigment in their leaves and is obtained from the roots of plant Scutellaria Baicalensis Georgi. Wogonin has long been used as an active anti-cancer drug in Chinese medicine practice. In recent past wogonin has shown to possess notable anti-inflammatory, and anti-allergic properties. Wogonin has demonstrated to possess anti-oxidant, anti-viral, anti-inflammatory and also anti-thrombotic properties.

Wogonin has shown to alleviate apoptosis, and ER stress in the cells and this property can also be used in the treatment of cardiovascular diseases. Notably, wogonin has been documented to have an extensive margin of safety as well as displays little or no organ toxicity following extended intravenous administration. In this review, we discuss recently discovered therapeutic potential of wogonin in the treatment of DCM.


Diabetic cardiomyopathy, wogonin, inflammation, diabetes mellitus, hyperglycemia, ER stress.


Department of Pathophysiology, Wuhan University School of Medicine, Hubei, Wuhan V, King Fahd Medical Research Center, King Abdulaziz University, P. O. Box 80216, Jeddah 21589

Read Full-Text article